These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4414691)

  • 1. Mode of action of ancrod as a defibrinating agent.
    Gaffney PJ; Brasher M
    Nature; 1974 Sep; 251(5470):53-4. PubMed ID: 4414691
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the subunit structure of human fibrin formed by the action of arvin, reptilase and thrombin.
    Mattock P; Esnouf MP
    Nat New Biol; 1971 Oct; 233(43):277-9. PubMed ID: 5288126
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
    Caprini JA; Kwaan HC; Zuckerman L; Verduin R
    Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
    [No Abstract]   [Full Text] [Related]  

  • 5. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot retraction in a factor XIII free system.
    Rao KM; Newcomb TF
    Scand J Haematol; 1980 Feb; 24(2):142-8. PubMed ID: 7375813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method of antithrombin estimation using plasma defibrinates with ancrod.
    Howie PW; Prentice CR; McNicol GP
    Br J Haematol; 1973 Jul; 25(1):101-10. PubMed ID: 4799764
    [No Abstract]   [Full Text] [Related]  

  • 8. Defibrinating enzyme from timber rattlesnake (Crotalus h. horridus) venom: a potential agent for therapeutic defibrination. I. Purification and properties.
    Bonilla CA
    Thromb Res; 1975 Feb; 6(2):151-69. PubMed ID: 1167709
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Bothrops jararaca venom on fibrin formation in vitro.
    Ponari O; Civardi E
    Arzneimittelforschung; 1973 Jan; 23(1):94-8. PubMed ID: 4740702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of products D and E on the thrombin induced conversion of fibrinogen to fibrin.
    Arnesen H
    Scand J Haematol; 1974; 12(3):165-72. PubMed ID: 4208835
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity.
    Silberman S; Bernik MB; Potter EV; Kwaan HC
    Br J Haematol; 1973 Jan; 24(1):101-13. PubMed ID: 4197581
    [No Abstract]   [Full Text] [Related]  

  • 14. Excercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates.
    Gurewich V; Lipinska I; Lipinski B
    Thromb Res; 1974 Nov; 5(5):647-56. PubMed ID: 4445987
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
    Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG
    Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of Arvin on Fibrin Stabilizing Factor (factor 13).
    Barlow GH; Holleman WH; Lorand L
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):39-42. PubMed ID: 5535658
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for aggregation of fibrin fragments D and E in soluble fibrin complex formation.
    Chang ML; Latallo ZS; Bang NU; Mattler LE; Hansen MS
    Thromb Res; 1974 Dec; 5(6):719-34. PubMed ID: 4445994
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.